Company
Krka
Pharmaceutical · Slovenia
Available Indicators
136 indicators for Krka. Each opens with a chart and the full value history.
Cost Per Employee (Local Currency) (EUR per month)yearly 2003-2015Net Profit (EUR mil)yearly 2000-2015ROE (%)yearly 2000-2015Employeesyearly 2003-2015Price/Book Value (P/BV)yearly 2000-2015Price/Earnings (P/E)yearly 2000-2015ROA (%)yearly 2000-2015Total Assets (EUR mil)yearly 2000-2015Book Value Per Share (EUR)yearly 2000-2015Cost Per Employee (USD per month)yearly 2003-2015Dividend Per Share (EUR)yearly 2000-2014Dividends (EUR mil)yearly 2000-2014Dividend Yield (%)yearly 2000-2014Earnings Per Share (EPS) (EUR)yearly 2000-2015Pre-Tax Profit (EUR mil)yearly 2000-2015Earnings Per Share Growth (%)yearly 2001-2015Revenues From Abroad (EUR mil)yearly 2008-2015Shareholders' Equity (EUR mil)yearly 2000-2015Staff Cost (As % Of Total Cost) (%)yearly 2001-2015Animal Health Pharmaceuticals - Antiparasitics For Good Producing Animals (As % of Sales) (%)yearly 2008-2015Animal Health Pharmaceuticals - General Anti-Infectives For Good Producing Animals (As % of Sales) (%)yearly 2008-2015Animal Health Pharmaceuticals - Other Products For Good Producing Animals (As % of Sales) (%)yearly 2008-2015Book Value Per Share Growth (%)yearly 2001-2015Capital Employed (EUR mil)yearly 2000-2015Capital Expenditures (EUR mil)yearly 2001-2015Capital Expenditures (As % of Sales) (%)yearly 2001-2015Cash & Cash Equivalents (EUR mil)yearly 2000-2015Cash Conversion Cycle (days)yearly 2000-2015Cash Earnings (EUR mil)yearly 2000-2015Cash Earnings Per Share (EUR)yearly 2000-2015Change in Working Capital (EUR mil)yearly 2001-2015Cost of Financing (%)yearly 2001-2015Cost of Goods & Services (EUR mil)yearly 2000-2015Current Assets (EUR mil)yearly 2000-2015Current Liabilities (EUR mil)yearly 2000-2015Days Payable Outstanding (days)yearly 2000-2015Days Sales Of Inventory (days)yearly 2000-2015Days Sales Outstanding (days)yearly 2000-2015Deferred Tax Liabilities (EUR mil)yearly 2010-2015Depreciation (EUR mil)yearly 2000-2015Dividends Paid (EUR mil)yearly 2001-2014Domestic Sales (EUR mil)yearly 2008-2015EBIT (EUR mil)yearly 2000-2015EBITDA (EUR mil)yearly 2000-2015EBITDA Growth (%)yearly 2001-2015EBITDA Margin (%)yearly 2000-2015EBIT Growth (%)yearly 2001-2015EBIT Margin (%)yearly 2000-2015Effective Tax Rate (%)yearly 2000-2015Enterprise Value (EV) (USD mil)yearly 2000-2015Equity And Liabilities (EUR mil)yearly 2000-2015Equity (As % Of Assets)yearly 2000-2015EV/Capital Employedyearly 2000-2015EV/EBITyearly 2000-2015EV/EBITDAyearly 2000-2015EV/Salesyearly 2000-2015Extraordinary Cost (EUR mil)yearly 2000-2015Financing Cost (EUR mil)yearly 2000-2015Free Cash Flow (EUR mil)yearly 2001-2015Free Cash Flow Yield (%)yearly 2001-2015Gross Margin (%)yearly 2000-2015Gross Profit (EUR mil)yearly 2000-2015Intangible Assets (EUR mil)yearly 2000-2015Inventories (EUR mil)yearly 2000-2015Issuance Of Debt (EUR mil)yearly 2001-2015Liabilities (EUR mil)yearly 2000-2015Long-Term Debt (EUR mil)yearly 2000-2015Market Capitalisation (USD mil)yearly 2000-2015Minorities (EUR mil)yearly 2000-2015Net Change In Cash (EUR mil)yearly 2001-2015Net Debt (EUR mil)yearly 2000-2015Net Debt/EBITDAyearly 2000-2015Net Debt/Equityyearly 2000-2015Net Debt Growth (%)yearly 2001-2015Net Margin (%)yearly 2000-2015Net Profit Growth (%)yearly 2001-2015Non-Cash Items (EUR mil)yearly 2001-2015Non-Current Assets (EUR mil)yearly 2000-2015Non-Current Liabilities (EUR mil)yearly 2000-2015Non-Prescription Pharmaceuticals - Alimentary Tract & Metabolism (As % of Sales) (%)yearly 2008-2015Non-Prescription Pharmaceuticals - Analgetics (As % of Sales) (%)yearly 2008-2015Non-Prescription Pharmaceuticals - Cough & Cold Products (As % of Sales) (%)yearly 2008-2015Non-Prescription Pharmaceuticals - Hari & Scalp Treatment (As % of Sales) (%)yearly 2011-2014Non-Prescription Pharmaceuticals - Herbals (As % of Sales) (%)yearly 2008-2008Non-Prescription Pharmaceuticals - Improvements Cerebral & Peripheral Circulation (As % of Sales) (%)yearly 2011-2015Non-Prescription Pharmaceuticals - Sore Throat Products (As % of Sales) (%)yearly 2011-2015Non-Prescription Pharmaceuticals - Vitamins & Minerals (As % of Sales) (%)yearly 2008-2015Number Of Shares (mil)yearly 2000-2015Of Which Minority Interest (EUR mil)yearly 2000-2015Operating Cost Growth (%)yearly 2002-2015Other Cost (EUR mil)yearly 2001-2015Other Investments (EUR mil)yearly 2001-2015Payout Ratio (%)yearly 2000-2014 · quarterly 2003-2014Prescription Pharmaceuticals - Alimentary Tract & Metabolism (As % of Sales) (%)yearly 2008-2015Prescription Pharmaceuticals - Anti-Infectives (As % of Sales) (%)yearly 2008-2015Prescription Pharmaceuticals - Blood & Blood-Forming Organs (As % of Sales) (%)yearly 2008-2015Prescription Pharmaceuticals - Cardiovascular System (As % of Sales) (%)yearly 2008-2015Prescription Pharmaceuticals - Central Nervous System (As % of Sales) (%)yearly 2008-2015Prescription Pharmaceuticals - Genito-Urinary System & Sex Hormones (As % of Sales) (%)yearly 2008-2015Pre-Tax Profit Growth (%)yearly 2001-2015Price/Cash Earnings (P/CE)yearly 2000-2015Property, Plant & Equipment (EUR mil)yearly 2000-2015Provisions (EUR mil)yearly 2014-2015Receivables (EUR mil)yearly 2000-2015Revenues From Abroad (As % Of Total) (%)yearly 2008-2015ROCE (%)yearly 2001-2015ROTEyearly 2001-2015Sales (EUR mil)yearly 2000-2015Sales from Animal Health Products (EUR mil)yearly 2002-2015Sales from Cosmetics (EUR mil)yearly 2002-2009Sales from Health Resort & Tourist Services (EUR mil)yearly 2002-2015Sales from Human Health Products (EUR mil)yearly 2002-2015Sales from Human Health Products (Non-Prescription Products) (EUR mil)yearly 2002-2015Sales from Human Health Products (Prescription Pharmaceuticals) (EUR mil)yearly 2002-2015Sales from Material & Merchandise (EUR mil)yearly 2010-2015Sales from Products (EUR mil)yearly 2010-2015Sales From Services (EUR mil)yearly 2010-2015Sales in Central Europe (EUR mil)yearly 2002-2015Sales in Eastern Europe (EUR mil)yearly 2002-2015Sales in Slovenia (EUR mil)yearly 2002-2015Sales in South-East Europe (EUR mil)yearly 2002-2015Sales in Western Europe & Overseas Markets (EUR mil)yearly 2002-2015Shareholders' Equity Growth (%)yearly 2001-2015Share Price (EUR)yearly 2000-2015Short-Term Debt (EUR mil)yearly 2000-2015Staff Cost (EUR mil)yearly 2001-2015Tax (EUR mil)yearly 2000-2015Total Asset Growth (%)yearly 2001-2015Total Cash From Financing (EUR mil)yearly 2001-2015Total Cash From Investing (EUR mil)yearly 2001-2015Total Cash From Operations (EUR mil)yearly 2001-2015Total Debt (EUR mil)yearly 2000-2015Total Debt Growth (%)yearly 2001-2015Total Revenue Growth (%)yearly 2001-2015Trade Payables (EUR mil)yearly 2000-2015Working Capital (EUR mil)yearly 2000-2015
Whole Company
$19.99 one-off
- ✓ All 136 indicators of Krka
- ✓ Full history, all frequencies
- ✓ Excel download
- ✓ Source & methodology included
Download Excel